Skip to main content
Figure 6 | BMC Pharmacology

Figure 6

From: Tuberous sclerosis preclinical studies: timing of treatment, combination of a rapamycin analog (CCI-779) and interferon-gamma, and comparison of rapamycin to CCI-779

Figure 6

Early rapamycin treatment is more effective than early CCI-779 treatment in nude mice bearing Tsc2-/- tumors. All animals were treated with 8 mg/kg of indicated drug five days per week. a) Average tumor growth over time for indicated cohorts. b) Survival curve for the early rapamycin and early CCI-779-treated cohorts. c) Data shown in table format.

Back to article page

BMC Pharmacology

ISSN: 1471-2210